171 related articles for article (PubMed ID: 16381642)
1. [Clinical and laboratory characteristics of anti-soluble liver antigen/liver-pancreas (SLA/LP) autoantibody positive liver disease patients].
Liu YM; Yan HP; Tan YF; Liu Y; Feng X; Kong SL
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):927-9. PubMed ID: 16381642
[TBL] [Abstract][Full Text] [Related]
2. [The significance of anti-soluble liver antigen/liver-pancreas in diagnosing and typing autoimmune hepatitis].
Zhao Y; Yan HP; Tan YF; Feng X; Liu Y; Cui D; Ma DM; Li WH; Zhang HP
Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):283-6. PubMed ID: 17456317
[TBL] [Abstract][Full Text] [Related]
3. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
4. [Presence of SLA/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome)].
Kanzler S; Bozkurt S; Herkel J; Galle PR; Dienes HP; Lohse AW
Dtsch Med Wochenschr; 2001 Apr; 126(16):450-6. PubMed ID: 11360449
[TBL] [Abstract][Full Text] [Related]
5. Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas.
Herkel J; Heidrich B; Nieraad N; Wies I; Rother M; Lohse AW
Hepatology; 2002 Feb; 35(2):403-8. PubMed ID: 11826415
[TBL] [Abstract][Full Text] [Related]
6. Significance of antibodies to soluble liver antigen/liver pancreas: a large French study.
Eyraud V; Chazouilleres O; Ballot E; Corpechot C; Poupon R; Johanet C
Liver Int; 2009 Jul; 29(6):857-64. PubMed ID: 19302185
[TBL] [Abstract][Full Text] [Related]
7. [The positive rate of auto antibodies and autoimmune liver diseases in patients with abnormal liver function].
Liu YM; Yan HP; Wang JT
Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):360-2. PubMed ID: 15225434
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies and autoantigens in autoimmune hepatitis.
Strassburg CP; Manns MP
Semin Liver Dis; 2002 Nov; 22(4):339-52. PubMed ID: 12447706
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease.
Ma Y; Okamoto M; Thomas MG; Bogdanos DP; Lopes AR; Portmann B; Underhill J; Dürr R; Mieli-Vergani G; Vergani D
Hepatology; 2002 Mar; 35(3):658-64. PubMed ID: 11870381
[TBL] [Abstract][Full Text] [Related]
10. [Immunological characteristics of primary biliary cirrhosis patients].
Yan HP; Zhuang H; Liu YM; Feng X; Tan YF; Liu Y; Zhang X; Zhao CH
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):12-6. PubMed ID: 15670483
[TBL] [Abstract][Full Text] [Related]
11. [Detection and the production mechanism of antinuclear antibodies (ANA) and anti-liver/kidney microsomal tpe 1 antibodies (anti-LKM1) in patients with chronic hepatitis C].
Bai L; Lu HY; Feng ZR; Yu M; Li WG; Gong WB; Zhao NE; Xu XY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):278-81. PubMed ID: 20108773
[TBL] [Abstract][Full Text] [Related]
12. [A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis].
Bakker-Jonges LE; ter Borg PC; van Buuren HR; Hooijkaas H
Ned Tijdschr Geneeskd; 2006 Mar; 150(9):490-4. PubMed ID: 16553048
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
[TBL] [Abstract][Full Text] [Related]
14. Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis.
Volkmann M; Martin L; Bäurle A; Heid H; Strassburg CP; Trautwein C; Fiehn W; Manns MP
Hepatology; 2001 Mar; 33(3):591-6. PubMed ID: 11230739
[TBL] [Abstract][Full Text] [Related]
15. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis.
Wies I; Brunner S; Henninger J; Herkel J; Kanzler S; Meyer zum Büschenfelde KH; Lohse AW
Lancet; 2000 Apr; 355(9214):1510-5. PubMed ID: 10801173
[TBL] [Abstract][Full Text] [Related]
16. Low frequency of anti-SLA/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay.
Miyakawa H; Kawashima Y; Kitazawa E; Kawaguchi N; Kato T; Kikuchi K; Imai E; Fujikawa H; Hashimoto E; Schlumberger W
J Autoimmun; 2003 Aug; 21(1):77-82. PubMed ID: 12892738
[TBL] [Abstract][Full Text] [Related]
17. Frequency and significance of anti-glutathione S-transferase autoantibody (anti-GST A1-1) in autoimmune hepatitis.
Kato T; Miyakawa H; Ishibashi M
J Autoimmun; 2004 May; 22(3):211-6. PubMed ID: 15041041
[TBL] [Abstract][Full Text] [Related]
18. Anti-soluble liver antigen/liver-pancreas (SLA/LP) antibodies in pediatric patients with autoimmune hepatitis.
Vitozzi S; Djilali-Saiah I; Lapierre P; Alvarez F
Autoimmunity; 2002 Dec; 35(8):485-92. PubMed ID: 12765473
[TBL] [Abstract][Full Text] [Related]
19. [A prospective study on the prevalence and clinical significance of autoantibodies in patients with suspected nonalcoholic fatty liver disease].
Cho DH; Choi MS; Kim DH; Kim DY; Shim SG; Lee JH; Koh KC; Paik SW; Yoo BC; Rhee JC
Korean J Hepatol; 2005 Sep; 11(3):261-7. PubMed ID: 16177552
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactivity to cytokeratin 8/18 in patients with soluble liver antigen (SLA) positive autoimmune hepatitis (AIH type 3) is not sufficient for diagnostic use.
Martin L; Bäurle A; Fiehn W; Volkmann M
Clin Lab; 2000; 46(7-8):339-44. PubMed ID: 10934580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
